Analysis of the HIV-2 protease's adaptation to various ligands: characterization of backbone asymmetry using a structural alphabet

Sci Rep. 2018 Jan 15;8(1):710. doi: 10.1038/s41598-017-18941-3.

Abstract

The HIV-2 protease (PR2) is a homodimer of 99 residues with asymmetric assembly and binding various ligands. We propose an exhaustive study of the local structural asymmetry between the two monomers of all available PR2 structures complexed with various inhibitors using a structural alphabet approach. On average, PR2 exhibits asymmetry in 31% of its positions-i.e., exhibiting different backbone local conformations in the two monomers. This asymmetry was observed all along its structure, particularly in the elbow and flap regions. We first differentiated structural asymmetry conserved in most PR2 structures from the one specific to some PR2. Then, we explored the origin of the detected asymmetry in PR2. We localized asymmetry that could be induced by PR2's flexibility, allowing transition from the semi-open to closed conformations and the asymmetry potentially induced by ligand binding. This latter could be important for the PR2's adaptation to diverse ligands. Our results highlighted some differences between asymmetry of PR2 bound to darunavir and amprenavir that could explain their differences of affinity. This knowledge is critical for a better description of PR2's recognition and adaptation to various ligands and for a better understanding of the resistance of PR2 to most PR2 inhibitors, a major antiretroviral class.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbamates / metabolism*
  • Crystallography, X-Ray
  • Darunavir / metabolism*
  • Enzyme Inhibitors / metabolism*
  • Furans
  • HIV Protease / chemistry*
  • HIV Protease / metabolism*
  • Protein Binding
  • Protein Conformation
  • Protein Subunits / chemistry
  • Protein Subunits / metabolism
  • Sulfonamides / metabolism*

Substances

  • Carbamates
  • Enzyme Inhibitors
  • Furans
  • Protein Subunits
  • Sulfonamides
  • amprenavir
  • HIV Protease
  • p16 protease, Human immunodeficiency virus 2
  • Darunavir